Preparation method of recombinant human collagen III fragment concatemer

By constructing Pichia engineered bacteria and high-density fermentation technology that expresses recombinant human collagen III fragment tandem, the problems of low yield of recombinant collagen and high cost of purification and separation are solved, and efficient and stable collagen production is achieved, reducing the number of high-energy production and reducing the number of recombinant collagen production. The cost and maintain protein integrity.

CN118956933AActive Publication Date: 2024-11-15XIAN KUNCHUANG RONGYUAN BIOTECHNOLOGY CO LTD

Patent Information

Application Number
CN202411088380.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-09
Publication Date
2024-11-15
Estimated Expiration
2044-08-09

AI Technical Summary

Technical Problem

In the prior art, the production of recombinant collagen is low and the cost of purification and separation is high, which leads to expensive prices, limiting its wide application in the fields of medicine and medical beauty.

Method used

By constructing Pichia engineered bacteria expressing recombinant human collagen III fragment tandem, high-density fermentation technology and optimized purification methods are used to achieve efficient expression and efficient purification, and a uniform structure recombinant human collagen III fragment tandem is obtained. .

Benefits of technology

It has achieved efficient and stable production of recombinant human collagen with uniform structure, reducing production costs, simplifying operating procedures, suitable for industrial production, and maintaining protein integrity.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118956933A_ABST
    Figure CN118956933A_ABST
Patent Text Reader

Abstract

The invention relates to a preparation method of a recombinant human collagen III fragment concatemer. The amino acid sequence of the recombinant human collagen III fragment concatemer is shown as SEQ NO.2, the recombinant human collagen III fragment concatemer contains 396 amino acids, the molecular weight of a monomer is 46 kDa, and the molecular weight of a tripolymer is 138 kDa. The preparation method comprises the following steps: constructing pichia pastoris engineering bacteria of constitutive secretory expression recombinant human collagen III fragment concatemer, and screening to obtain efficiently expressed pichia pastoris engineering bacteria; carrying out high-density fermentation culture on the recombinant yeast to realize high-efficiency expression of the recombinant human collagen III fragment concatemer; and separating and purifying the recombinant human collagen III fragment concatemer protein from the fermentation liquor. The recombinant human collagen III fragment concatemer is a brand new amino acid sequence completely composed of human collagen III fragments, and a gene coded by the recombinant human collagen III fragment concatemer is a brand new artificial gene sequence; according to the invention, the fermentation production of the collagen engineering bacteria is easily realized.
Need to check novelty before this filing date? Find Prior Art

Description

Technical field:

[0001] The present invention relates to the field of biotechnology, and in particular to a method for preparing a highly hydrophilic recombinant human collagen fragment concatemer. Background technology:

[0002] Collagen III is an important component of various human tissues, especially in the vascular wall, internal organs and embryos, it plays a key role in maintaining organ structure and elasticity. Collagen tubes are mainly used for artificial blood vessels, artificial vascular catheters for vascular stenosis and embolism treatment, nerve repair catheters, etc. Its medicinal value is mainly reflected in wound healing, joint health and bone health; its medical and aesthetic value is mainly reflected in beauty and skin care, anti-aging and filling and shaping.

[0003] Natural collagen itself has hemostatic function, which can promote platelet aggregation and plasma clots. Collagen can be used as an attachment and scaffold for cell growth, and can induce the proliferation of epithelial cells, etc. The biodegradability of collagen allows collagen to be used as an organ transplant material. Collagen has a certain mechanical strength and is currently widely used in cosmetic fillings. At present, collagen is the new favorite of biomedicine and biomedical materials, among which collagen solutions are mainly used to repair skin tissue, soft tissue filling materials, bone tissue regeneration fillers, etc.; collagen sponges are mainly used for surgical hemostasis, oral resorbable dressings, tissue filling, tissue engineering scaffolds, etc., collagen membranes are mainly used to promote the regeneration of periodontal membranes, artificial skin, skin coverings for burns and scalds, and promote the healing of skin corneal epithelial cells, etc.; collagen particles are mainly used for fracture and bone defect fillers, drug sustained release, etc.;

[0004] At present, one method is to generate collagen by proteolysis using animal skin tissue (pig skin, fish skin, donkey skin, etc.). The produced collagen has a stable composition and biological activity, but it often has composition heterogeneity, obvious antigenicity and hidden dangers of zoonotic viruses, which limits their wide application in the fields of medicine and medical beauty. At present, genetic recombination technology is the main method for producing recombinant human collagen. The pyrogen easily produced when Escherichia coli expresses collagen makes the expression product difficult to apply clinically; at the same time, the target protein is often expressed in the form of inclusion bodies, which makes it difficult to purify the product; the post-translational processing and modification system of the prokaryotic expression system is imperfect, and collagen itself has more disulfide bonds, which leads to the low biological activity of the prokaryotic expression product. To obtain recombinant collagen with better performance, it is necessary to undergo sufficient post-translational modification by eukaryotes, including hydroxylation and glycosylation. In 1997, the Collagen Research Center of the University of Oulu in Finland first used Pichia pastoris to express human collagen, but the expression level was too low. After the analysis of the collagen structure and yeast expression attempts, it is possible to successfully express collagen fragments with high efficiency. In 2012, Liu Bin and others used Pichia pastoris to efficiently secrete highly hydrophilic human-like recombinant collagen dimers through methanol induction. According to many reports, the recombinant expression of human collagen in yeast has become a research hotspot, making its industrialization possible. Due to the many medicinal values ​​of collagen, the domestic and international market demand for collagen has always been great. At present, recombinant collagen is expensive due to its low yield and high purification and separation costs. Therefore, it is of great application value to develop a method for preparing collagen that is efficient, provides a stable source, and maintains the integrity of the protein structure. Summary of the invention:

[0005] The purpose of the present invention is to provide a method for preparing a recombinant human collagen III fragment concatemer, which is used to solve the problems of low recombinant collagen yield, high purification and separation costs, and high prices in the prior art.

[0006] The technical solution adopted by the present invention to solve the technical problem is: the preparation method of the recombinant human collagen III fragment concatemer comprises the following steps:

[0007] Step 1: construct a Pichia pastoris engineering bacterium expressing a recombinant human collagen III fragment concatemer, and screen and obtain a Pichia pastoris engineering bacterium with high expression efficiency:

[0008] (1) Based on the codon preference of Pichia pastoris, the amino acid sequence of the tandem fragment of human collagen III was used as the basis, and the high-frequency codons of Pichia pastoris were used to optimize it, adding the TGA termination codon, with a total length of 1191 bp, named 396C, and the gene optimization result is shown in SEQ NO.3;

[0009] (2) The optimized gene was inserted into the constitutive secretory expression vector pGAPZaA of Pichia pastoris through seamless synthesis; then Escherichia coli was transformed to construct and screen positive strains containing pGAPZa-396; the linearized pGAPZa-396CDNA was transformed into Pichia pastoris SDM1168 to express the human collagen III fragment concatemer, and the genetically engineered Pichia pastoris was screened;

[0010] Step 2: High-density fermentation culture of the recombinant yeast to achieve efficient expression of the recombinant human collagen III fragment concatemer;

[0011] Step 3: Separate and purify the recombinant human collagen III fragment concatemer protein from the fermentation broth.

[0012] In the above scheme, the recombinant human collagen III fragment concatemer is based on the tripeptide repeat sequence characteristics and strong hydrophilicity of Gly-XY in the collagen domain of the α1 chain of human type III collagen. A 99 amino acid fragment from amino acid 981 to amino acid 1079 of human collagen III is selected and concatenated 4 times to obtain a structure containing 396 amino acids, as shown in SEQ NO.2, with a monomer molecular weight of 46 kDa and a trimer molecular weight of 138 kDa; the 99 amino acid fragment from amino acid 981 to amino acid 1079 of human collagen III is shown in SEQ NO.1.

[0013] The specific steps of step 2 of the above scheme are:

[0014] High-density fermentation technology was used, with YPD medium as the basic medium, and indirect fed-batch culture was used to increase the cell density and protein expression of the genetically engineered strain of Pichia pastoris. At the same time, the seed medium was YPD, the loading volume of the triangular flask was 1 / 5 of the capacity, the culture conditions were 30℃230rmp, and when OD 600 =1.3-1.5 and 4°C for standby use; the fermentation medium formula is 2% peptone, 1% yeast extract, 2.5% glucose, 0.02% folate, the inoculation amount is 10%, the optimal fermentation conditions are 30°C, the ventilation volume is 1.3-1.5vvm, the tank pressure is 0.17-0.3MPa, the stirring speed is 300-350r / min, the dissolved oxygen is>30%, and the volume fraction of ammonia water is 20% to maintain the pH value at 7.2-7.5; after fermentation for 18 hours, 20% sterile glucose and a sterile mixed solution containing 20% ​​peptone and 10% yeast extract are used for feeding respectively, and the feeding time is 36 hours to maintain the fermentation liquid containing 1% glucose concentration. When the bacterial mass concentration reaches 320g / L and OD 600 When it reaches 300, put it into the tank and ferment it for 60-62 hours.

[0015] Step 3 of the above scheme is specifically as follows:

[0016] The fermentation broth was centrifuged at 4°C and 8000-10000g for 10 minutes, and the supernatant was taken; ammonium sulfate powder was slowly added during stirring to make the ammonium sulfate saturation of the solution reach 50%, and then centrifuged at 4°C and 9000-10000g for 15 minutes, and the precipitate was taken. The precipitate was washed once with 50% ammonium sulfate solution, centrifuged at 9000-10000g for 15 minutes, and the precipitate was dissolved with distilled water. After the precipitate was centrifuged at 4°C and 9000-10000g for 15 minutes, the supernatant was taken; the supernatant was desalted with Sephadex G-50 and a solution of 20mm Tris-Cl pH 7.5, and the 280nm ultraviolet detection peak solution was collected; Q Seplife FF ion exchange was then used for column chromatography, and the column was equilibrated with 20mm Tris-Cl pH 7.5 buffer. After loading, pH 7.5, 20mm Tris-Cl plus 1M NaCl were used for linear elution, and 20mm Tris-Cl plus 0.15M The elution peak of NaCl was detected by 280nm ultraviolet light; then, Sephadex G-100 gel column chromatography was used for separation and purification, eluted with PBS solution, and the liquid with the largest peak was collected as the target protein. The solution was concentrated by ultrafiltration with a molecular weight cutoff of 30kDa, and then freeze-dried to obtain the recombinant human collagen III fragment concatemer.

[0017] The above scheme produces 6-7 g / L of recombinant human collagen III fragment concatemer.

[0018] The present invention has the following beneficial effects:

[0019] 1. The present invention provides a method for constitutively and efficiently secreting and expressing recombinant human collagen III fragment concatemers using recombinant Pichia pastoris and a technology for fermenting and extracting the recombinant collagen. The amino acid structure and gene of the recombinant human collagen are different from those currently reported. Compared with methanol-induced Pichia pastoris, the high-density fermentation is simpler and easier to operate, the fermentation cycle is shorter, the culture medium formula used is simpler and cheaper, and the purification and extraction method is more efficient and convenient.

[0020] 2. The recombinant human collagen III fragment concatemer of the present invention is a completely new amino acid sequence, but is completely composed of human collagen III fragments, and the gene encoded by it is a completely new artificial gene sequence; this method can easily realize the fermentation production of the collagen engineering bacteria, and the expressed recombinant protein has the characteristic of promoting the growth of fibroblasts.

[0021] 3. The present invention can efficiently and stably produce recombinant human collagen III fragment concatemers with uniform structure and maintain the integrity of its protein structure. Compared with the traditional Pichia pastoris methanol induction method, this method has better operability, lower culture medium cost, shorter fermentation time, and is more suitable for industrial production. Description of the drawings:

[0022] Figure 1 This is a map of the insertion sites of the human collagen III fragment concatemer gene in pGAPZaA.

[0023] Figure 2 This is a screen diagram for highly resistant recombinant strains.

[0024] Figure 3 The SDS-PAGE shows the protein expression of recombinant human collagen III fragment concatemers secreted by different recombinant yeast strains. The figure shows that the expression levels of the target protein in different recombinant yeast strains are significantly different. The arrow points to the target protein of the efficient expression strain.

[0025] Figure 4 This is the SDS-PAGE electrophoresis diagram of the target protein secreted and expressed by the recombinant yeast after 1-84 hours of fermentation. From right to left, the lanes in the figure are Marker, expression results of 24h, 48h, 60h, and 72h.

[0026] Figure 5 This is the SDS-PAGE electrophoresis diagram of the target protein precipitated at different ammonium sulfate saturations. From right to left, the lanes are Marker, 25%, 35%, 45% h, 55%, 60%, 65%, and 70% saturation precipitation effects.

[0027] Figure 6 This is the SDS-PAGE image of the recombinant human collagen III fragment concatemer after purification.

[0028] Figure 7 This is the non-denaturing 6% polyacrylamide electrophoresis of recombinant human collagen III fragment concatemer. Specific implementation method:

[0029] The present invention will be further described below in conjunction with the accompanying drawings:

[0030] The amino acid sequence of this recombinant human collagen III fragment concatemer is shown in SEQ NO.2, containing 396 amino acids, a monomer molecular weight of 46kDa, and a trimer molecular weight of 138kDa. The preparation method thereof is as follows: constructing a Pichia pastoris engineered bacterium that constitutively secretes and expresses the recombinant human collagen III fragment concatemer, screening and obtaining a Pichia pastoris engineered bacterium with high expression efficiency; performing high-density fermentation culture on the recombinant yeast to achieve high-efficiency expression of the recombinant human collagen III fragment concatemer; and separating and purifying the recombinant human collagen III fragment concatemer protein from the fermentation broth.

[0031] 1. Design and amino acid structure of recombinant human collagen III fragment concatemer

[0032] Based on the tripeptide repeat sequence characteristics and strong hydrophilicity of Gly-XY in the collagen domain of the α1 chain of human type III collagen, a 99 amino acid fragment from amino acid 981 to amino acid 1079 of human collagen III was selected as shown in SEQ NO.1, and the above fragment was concatenated 4 times to obtain the following 396 amino acid structure, as shown in SEQ NO.2.

[0033] 2. The construction of the gene and genetic engineering bacteria expressing the recombinant human collagen III fragment concatemer is as follows:

[0034] 1) According to the codon preference of Pichia pastoris, based on the amino acid sequence of the tandem fragment of human collagen III, it was optimized using the high-frequency codons of Pichia pastoris, and the TGA termination codon was added. The total length was 1191 bp and was named 396C. The gene optimization result is shown in SEQ NO.3 below.

[0035] 2) The optimized gene was inserted into the Pichia pastoris constitutive secretory expression vector pGAPZaA by seamless synthesis, as Figure 1 At the red arrow on the top, E. coli was then transformed to construct and screen positive strains containing pGAPZa-396. The linearized pGAPZa-396C DNA was transformed into Pichia pastoris SDM1168 to express the human collagen III fragment concatemer and screen the genetically engineered Pichia pastoris.

[0036] 3. The fermentation culture conditions of genetically engineered bacteria and the constitutive secretion expression conditions of recombinant human collagen III fragment concatemers are as follows:

[0037] High-density fermentation technology was used, with YPD medium as the base medium, and indirect fed-batch culture was used to increase the cell density and protein expression of the Pichia yeast engineering strain. At the same time, the seed medium was YPD, the loading volume of the triangular flask was 1 / 5 of the capacity, and the culture conditions were 30℃230rmp when OD 600 =1.3-1.5, 4℃ for standby use. The formula of the fermentation medium is 2% peptone, 1% yeast extract, 2.5% glucose, 0.02% folate, the inoculation amount is 10%, the optimal fermentation conditions are 30℃, the ventilation volume is 1.3-1.5vvm, the tank pressure is 0.17-0.3MPa, the stirring speed is 300-350r / min, the dissolved oxygen is>30%, and the volume fraction of ammonia water is 20% to maintain the pH value at 7.2-7.5; after 18 hours of fermentation, 20% sterile glucose and a sterile mixed solution containing 20% ​​peptone and 10% yeast extract are used for feeding, and the feeding time is 36 hours to maintain the fermentation liquid containing 1% glucose concentration. When the bacterial mass concentration reaches 320g / L and OD 600 When it reaches 300, put it into the tank and ferment it for 60-62 hours.

[0038] 4. The extraction and purification of recombinant human collagen III fragment concatemers are as follows:

[0039] The fermentation broth was centrifuged at 4°C and 8000-10000g for 10 minutes, and the supernatant was taken; ammonium sulfate powder was slowly added during stirring to make the ammonium sulfate saturation of the solution reach 50%, and then centrifuged at 4°C and 9000-10000g for 15 minutes, and the precipitate was taken. The precipitate was washed once with 50% ammonium sulfate solution, centrifuged at 9000-10000g for 15 minutes, and the precipitate was dissolved with distilled water. After the precipitate was centrifuged at 4°C and 9000-10000g for 15 minutes, the supernatant was taken; the supernatant was desalted with Sephadex G-50 and a solution of 20mm Tris-Cl pH 7.5, and the 280nm ultraviolet detection peak solution was collected; Q Seplife FF ion exchange was then used for column chromatography, and the column was equilibrated with 20mm Tris-Cl pH 7.5 buffer. After loading, pH 7.5, 20mm Tris-Cl plus 1M NaCl were used for linear elution, and 20mm Tris-Cl plus 0.15M The elution peak of NaCl was detected by ultraviolet at 280nm; then, Sephadex G-100 gel column chromatography was used for separation and purification, eluted with PBS solution, and the liquid with the largest peak was collected as the target protein. The solution was concentrated by ultrafiltration with a molecular weight cutoff of 30kDa, and then freeze-dried to obtain the finished product.

[0040] The preparation method of the recombinant human collagen III fragment concatemer is described in detail as follows:

[0041] Selection of human collagen III fragments

[0042] Amino acids from position 981 to 1079 of human collagen III are selected, and a 99-amino acid fragment containing three disulfide bonds is used as the concatenation basis. The sequence is the amino acid sequence of the basic fragment of human collagen III, see SEQ NO.1:

[0043]

[0044] Amino acid sequence of tandem fragments of human collagen III:

[0045] The above human collagen III basic fragment was connected in series four times to obtain the following 396 amino acid structure, the sequence of which is shown in SEQ NO.2:

[0046]

[0047] Codon-optimized gene construction:

[0048] According to the codon preference of Pichia pastoris, the amino acid sequence of the tandem fragment of human collagen III was used as the basis, and the high-frequency codons of Pichia pastoris were used to optimize it to avoid the AvrⅡ restriction site. The optimized artificial chemically synthesized gene sequence is as follows SEQ NO.3, It is a stop codon, with a total length of 1191 bp, named 396C, and the sequence is shown in SEQ NO.3:

[0049]

[0050] Construction of constitutive secretory expression recombinant yeast and screening of highly efficient expression recombinants:

[0051] The human collagen III fragment concatemer gene was inserted into the constitutive secretory expression vector pGAPZaA of Pichia pastoris by seamless chemical synthesis technology. Figure 1 Red arrow; then transform DH5a, screen the recombinant E. coli using low-salt LB plates containing 25ug / mL bleomycin, and perform PCR identification.

[0052] The recombinant Escherichia coli was cultured in a low-salt LB liquid medium containing 25ug / mL bleomycin, and the recombinant plasmid pGAPZa-396C was extracted using a plasmid extraction kit. The plasmid was then linearized using AvrII fast endonuclease, and the linearization result was detected by agarose electrophoresis. After the linearization was complete, phenol chloroform (1:1) was used for extraction once to remove the endonuclease, and then 1 / 10 volume of 3M sodium acetate and 2.5-3 times volume of anhydrous ethanol were added, and the precipitated linearized DNA was recovered by high-speed centrifugation, and the precipitate was washed twice with 80% ethanol. After drying, 12uL of deionized water was added, and the amount of DNA should reach 5-10ug.

[0053] Prepare SMD1168 Pichia competent cells, mix 10uL of linearized pGAPZa-396C with 80uL of SMD1168 competent cells, add to a 0.2cm electroporation cup, ice bath for 5min, use an electroporator at 1500v for electroporation, quickly add 1mL of 1M cold sorbitol after electroporation, place in a 15mL sterile centrifuge tube, let stand at 30℃ for 1-2h, then mix well and take 150uL of the solution to spread on a YPDS plate containing 100ug / mL bleomycin, invert and culture at 30℃ for 3-4 days until clones appear; then use a sterile pipette tip to spot the clones on a YPDS plate containing 500ug / mL bleomycin, invert and culture at 30℃ for 2-3 days, and see Figure 2, select the recombinant yeast strains with large colonies, inoculate them into YPD liquid culture medium containing 100ug / mL bleomycin, culture them in a shaker at 30℃ and 240rmp for 3 days, then centrifuge at 1500g for 5 minutes, take the supernatant, perform SDS-PAGE electrophoresis and thin layer scanning analysis, and screen the recombinant yeast that efficiently secretes and expresses the human collagen III fragment concatemer by examining the thickness of the stained target band, such as Figure 3 The arrows indicate highly expressed strains.

[0054] High density fermentation method:

[0055] A fully automatic fermentation tank was used, with YPD medium as the base medium, the liquid volume was 2 / 5, and high-density fermentation technology was used. Through indirect fed-batch culture, high-density fermentation technology was used to increase the cell density and protein expression of Pichia yeast engineering strains. At the same time, the seed culture medium was YPD, the loading volume of the triangular flask was 1 / 5 of the capacity, and the culture conditions were 30℃240rmp when OD600=1.3-1.5 and 4℃ for standby. The fermentation medium formula was 2% peptone, 1% yeast extract, 2.5% glucose, and 0.02% folate. High-density fermentation conditions: inoculation volume of 10%, optimal fermentation conditions of 30°C, oxygen flow of 1.3-1.5vvm, stirring speed of 300-350r / min, tank pressure of 0.18-0.3MPa, dissolved oxygen>30%, ammonia water with a volume fraction of 25%, pH value maintained at 7.2-7.5; after 18 hours of fermentation, a sterile mixed solution containing 20% ​​sterile glucose, 20% peptone and 10% yeast extract was used for feeding, and the fermentation liquid was maintained at a glucose concentration of 1%. The feeding time was 36 hours. When the bacterial mass concentration reached 320g / L and OD 600 When the temperature reaches 300, the tank is released and the fermentation time is 60-62 hours. As the fermentation time increases, the recombinant human collagen III fragment concatemer protein Figure 4 The expression level of the target protein shown gradually increased, and in the fermentation broth, the recombinant human collagen III fragment concatemer protein could reach 6-7 g / L.

[0056] Extraction method:

[0057] The fermentation liquid was centrifuged at 4°C and 8000-10000g for 10 minutes, and the supernatant was taken; ammonium sulfate powder was slowly added during stirring to make the solution ammonium sulfate saturation reach 50%, and then centrifuged at 4°C and 9000-10000g for 15 minutes, and the precipitate was taken. The precipitate was washed once with 50% ammonium sulfate solution, and centrifuged at 9000-10000g for 15 minutes, and the precipitate was collected. The ammonium sulfate precipitation effect was as follows: Figure 5; After the precipitate is dissolved with distilled water, centrifuge at 4°C and 9000-10000g for 15 minutes, and the supernatant is taken; the supernatant is desalted with Sephadex G-50 and solution 20mmTris-Cl pH 7.5, and the 280nm ultraviolet detection peak solution is collected; Q Seplife FF ion exchange is then used for column chromatography, and the column is equilibrated with 20mm Tris-Cl pH 7.5 buffer. After loading, pH 7.5, 20mmTris-Cl plus 1M NaCl are used for linear elution, and the 280nm ultraviolet detection peak of 20mm Tris-Cl plus 0.15M NaCl is collected; then Sephadex G-100 gel column chromatography is used for separation and purification, eluted with PBS solution, and the liquid with the largest peak is collected as the target protein. The solution is concentrated by ultrafiltration with a molecular weight cutoff of 30kDa, and then freeze-dried to obtain the finished product, which is ≥96% high-purity recombinant human collagen III fragment concatemer protein, as shown Figure 6 shown.

[0058] Protein structure identification:

[0059] The monomer molecular weight of the recombinant human collagen III concatemer was 46 KDa as determined by SDS-PAGE. Figure 2 Theoretical prediction is 35208Da, and the molecular weight measured by high-resolution XevoG2-XS QTof (Waters) mass spectrometry is 35263.5Da. Figure 7 Analysis showed that the recombinant human collagen III fragment concatemer was a trimer.

[0060] The predicted isoelectric point of the protein is 5.8. The pI of the recombinant human collagen III concatemer was 6.0-6.2 as measured by isoelectric electrophoresis, which is slightly larger than predicted.

[0061] Infrared spectral scanning analysis, the wave numbers of amide A, amide B, amide I, amide II, and amide III can determine that the recombinant protein has similar structural characteristics to natural collagen.

[0062] Using the MTT method to determine, the recombinant collagen at a concentration greater than 0.1 mg / mL can significantly promote the growth of NIH3T3 cells.

[0063] According to AlphaFold prediction, the recombinant human collagen III fragment concatemer has a similarity of 64% with human collagen I chain and a structural correctness of 73%; the recombinant human collagen III fragment concatemer has a similarity of 64% with human collagen a-1 chain and a structural correctness of 72%, indicating that the recombinant human collagen III fragment concatemer has similar functionality.

Claims

1. A method for preparing a recombinant human collagen III fragment concatemer, characterized in that The steps include: Step 1: construct a Pichia pastoris engineering bacterium expressing a recombinant human collagen III fragment concatemer, and screen and obtain a Pichia pastoris engineering bacterium with high expression efficiency: (1) Based on the codon preference of Pichia pastoris, the amino acid sequence of the tandem fragment of human collagen III was used as the basis, and the high-frequency codons of Pichia pastoris were used to optimize it, adding the TGA termination codon. The total length was 1191 bp and was named 396C. The gene optimization result is shown in SEQ NO.3; (2) The optimized gene was inserted into the constitutive secretory expression vector pGAPZaA of Pichia pastoris through seamless synthesis; then Escherichia coli was transformed to construct and screen positive strains containing pGAPZa-396; the linearized pGAPZa-396CDNA was transformed into Pichia pastoris SDM1168 to express the human collagen III fragment concatemer, and the genetically engineered Pichia pastoris was screened; Step 2: High-density fermentation culture of the recombinant yeast to achieve efficient expression of the recombinant human collagen III fragment concatemer; Step 3: Separate and purify the recombinant human collagen III fragment concatemer protein from the fermentation broth.

2. The method for preparing the recombinant human collagen III fragment concatemer according to claim 1, characterized in that: The recombinant human collagen III fragment concatemer is based on the tripeptide repeat sequence characteristics and strong hydrophilicity of the Gly-XY tripeptide repeat sequence of the α1 chain collagen domain of human type III collagen. A 99 amino acid fragment from amino acid 981 to amino acid 1079 of human collagen III is selected and concatenated 4 times to obtain a structure containing 396 amino acids, as shown in SEQ NO.2, with a monomer molecular weight of 46 kDa and a trimer molecular weight of 138 kDa; the 99 amino acid fragment from amino acid 981 to amino acid 1079 of human collagen III is shown in SEQ NO.

1.

3. The method for preparing the recombinant human collagen III fragment concatemer according to claim 2, characterized in that: The step 2 is specifically as follows: High-density fermentation technology was used, with YPD medium as the basic medium, and indirect fed-batch culture was used to increase the cell density and protein expression of the genetically engineered strain of Pichia pastoris. At the same time, the seed medium was YPD, the loading volume of the triangular flask was 1 / 5 of the capacity, the culture conditions were 30℃ 230rmp, and when OD 600 =1.3-1.5 and 4℃ for standby use; the formula of the fermentation medium is 2% peptone, 1% yeast extract, 2.5% glucose, 0.02% folate, the inoculation amount is 10%, the optimal fermentation conditions are 30℃, the ventilation volume is 1.3-1.5vvm, the tank pressure is 0.17-0.3MPa, the stirring speed is 300-350 r / min, the dissolved oxygen is>30%, and the volume fraction of ammonia water is 20% to maintain the pH value at 7.2-7.5; after 18 hours of fermentation, 20% sterile glucose and a sterile mixed solution containing 20% ​​peptone and 10% yeast extract are used for feeding, and the feeding time is 36 hours to maintain the fermentation liquid containing 1% glucose concentration. When the bacterial mass concentration reaches 320g / L and OD 600 When it reaches 300, put it into the tank and ferment it for 60-62 hours.

4. The method for preparing the recombinant human collagen III fragment concatemer according to claim 3, characterized in that: The step three is specifically as follows: The fermentation broth was centrifuged at 4°C and 8000-10000g for 10 minutes, and the supernatant was taken; ammonium sulfate powder was slowly added during stirring to make the ammonium sulfate saturation of the solution reach 50%, and then centrifuged at 4°C and 9000-10000g for 15 minutes, and the precipitate was taken. The precipitate was washed once with 50% ammonium sulfate solution, centrifuged at 9000-10000g for 15 minutes, and the precipitate was dissolved with distilled water. After the precipitate was centrifuged at 4°C and 9000-10000g for 15 minutes, the supernatant was taken; the supernatant was desalted with Sephadex G-50 and 20mm Tris-Cl pH 7.5 solution, and the 280nm UV detection peak solution was collected; Q Seplife FF ion exchange was then used for column chromatography, and the column was equilibrated with 20mm Tris-Cl pH 7.5 buffer. After loading, pH 7.5, 20mm Tris-Cl plus 1M NaCl were used for linear elution, and 20mmTris-Cl plus 0.15M The elution peak of NaCl was detected by 280nm ultraviolet light; then Sephadex G-100 gel column chromatography was used for separation and purification, eluted with PBS solution, and the liquid with the largest peak was collected as the target protein. The solution was concentrated by ultrafiltration with a molecular weight cutoff of 30 kDa, and then freeze-dried to obtain the recombinant human collagen III fragment concatemer.

5. The method for preparing the recombinant human collagen III fragment concatemer according to claim 4, characterized in that: The yield of the recombinant human collagen III fragment concatemer reaches 6-7 g / L.

Citation Information

Patent Citations

  • Recombinant human III-type collagen and pichia pastoris recombinant expression system thereof

    CN112552393A

  • High-stability recombinant collagen as well as construction method and application thereof

    CN116082493A

  • Recombinant III-type collagen, nucleic acid, expression vector, bacterial strain and application of recombinant III-type collagen

    CN116284339A

  • Recombinant micromolecular collagen as well as expression system and preparation method thereof

    CN116948013A

  • Recombinant humanized III-type triple helix collagen as well as preparation method and application thereof

    CN118290567A

Cited By

  • Recombinant collagen III + X as well as preparation method and application thereof

    CN121203036A

  • Recombinant collagen iii+x and preparation method and application thereof

    CN121203036B

  • V-type recombinant collagen with stable expression as well as preparation method and application of V-type recombinant collagen

    CN122080181A

  • IV type recombinant collagen as well as preparation method and application thereof

    CN122080182A